Wells Fargo raises RenaissanceRe target to $329

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Wells Fargo analyst Elyse Greenspan maintained an Equal-Weight rating on RenaissanceRe Holdings while raising the price target to $329 from $306. This follows similar target increases by Cantor Fitzgerald, Morgan Stanley, TD Cowen, and Keefe, Bruyette & Woods.

powered bylight_fuzz_icon
44902605

*this image is generated using AI for illustrative purposes only.

Wells Fargo analyst Elyse Greenspan has raised the price target for RenaissanceRe Holdings to $329 from $306 while maintaining an Equal-Weight rating. This adjustment adds to a series of upward revisions by major financial institutions, reflecting a positive outlook for the insurer. RenaissanceRe Holdings trades on the NYSE under the ticker symbol RNR.

Cantor Fitzgerald analyst Ryan Tunis previously raised the price target to $354 from $340 with an Overweight rating. Morgan Stanley analyst Michael Phillips increased the objective to $320 from $310, keeping an Equal-Weight rating. TD Cowen analyst Andrew Kligerman lifted the target to $315 from $300 with a Hold rating. Additionally, Keefe, Bruyette & Woods analyst Meyer Shields raised the price target to $342 from $327 while maintaining a Market Perform rating.

Firm Analyst New Target Previous Target Rating
Wells Fargo Elyse Greenspan $329 $306 Equal-Weight
Cantor Fitzgerald Ryan Tunis $354 $340 Overweight
Morgan Stanley Michael Phillips $320 $310 Equal-Weight
TD Cowen Andrew Kligerman $315 $300 Hold
Keefe, Bruyette & Woods Meyer Shields $342 $327 Market Perform
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific market conditions are driving the consensus for higher price targets among analysts?

How might RenaissanceRe's underwriting performance impact future earnings relative to these revised targets?

Could the divergence in ratings (e.g., Overweight vs. Hold) signal differing views on the insurer's risk exposure?

like20
dislike

RenaissanceRe schedules Q2 2026 results conference call

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

RenaissanceRe Holdings Ltd. announced it will release its Q2 2026 financial results on July 22, 2026, followed by a conference call on July 23, 2026, to discuss performance and outlook. Access to the live webcast and replay will be provided via the company's investor relations website.

powered bylight_fuzz_icon
44572640

*this image is generated using AI for illustrative purposes only.

RenaissanceRe Holdings Ltd. will release its financial results for the second quarter of 2026 following the close of market on Wednesday, July 22, 2026. The company has scheduled an investment community conference call to discuss these results and its business outlook for 10:00 a.m. ET on Thursday, July 23, 2026.

Investors can access a live webcast of the conference call through the Investors section of RenaissanceRe’s website at investor.renre.com. A replay of the call will be made available at the same location following the conclusion of the event.

RenaissanceRe operates as a global provider of reinsurance and insurance, specializing in matching desirable risk with efficient capital. The company offers property, casualty, and specialty reinsurance along with certain insurance solutions, primarily distributed through intermediaries.

Headquartered in Bermuda, RenaissanceRe was established in 1993 and maintains a network of offices across North America, Europe, and the Asia-Pacific region.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What factors might influence RenaissanceRe's business outlook for the remainder of 2026?

How could recent trends in the reinsurance market impact RenaissanceRe's Q2 2026 financial results?

What strategic initiatives is RenaissanceRe pursuing to expand its market presence in the Asia-Pacific region?

like16
dislike
Must Read Next

Earnings

Sai Silks Q2FY27 Results: Revenue at ₹434 crore, opens 4 stores 3 mins ago
no imag found
Sedemac Mechatronics Latest Results: ECU sales up 37.5% YoY to 1,452,867 units 4 mins ago

Stocks

Studds Accessories receives occupation certificate for Faridabad Facility-V 4 mins ago
no imag found
Maharashtra FDA cancels Cipla unit's drug sale licence over violations 4 mins ago
Maharashtra GST officials search Sudarshan Chemical offices under Section 67 4 mins ago